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The switch from IgM to IgG (or IgA, IgE) synthesis has been studied in both 
normal  and  neoplastic  Ig-secreting  cells  (1-6).  Evidence  suggests  that  DNA 
rearrangements precede isotype switching. The nature of the signals that induce 
isotype switching are not understood, although T  cells  (7-13),  T  cell-derived 
lymphokines (14-20), and mitogens (20-22) can influence switching in activated 
B cells. 
We have previously (16)  described a  T  cell-derived lymphokine termed "B 
cell differentiation factor for IgG" (BCDF3,), l  that induces increased levels of 
IgG1  secretion  in  lipopolysaccharide (LPS)-stimulated splenic  B  cells.  T  cell 
supernatants (SN) containing BCDF3, also contain lymphokines that suppress the 
secretion of IgG3 (23)  and IgG2 (24,  25).  These changes in IgG secretion are 
accompanied by corresponding changes in the steady state levels of mRNA for 
each  IgG subclass  (23).  BCDF3,-containing SN  do  not  act  on  cells  that  bear 
surface IgG (sIgG) at the initiation of culture (16).  Furthermore, BCDF7 does 
not bind to Sepharose-coupled IgM, IgD, or IgG (25).  The cell surface receptor 
for BCDF3,,  then, is probably not sIg. 
The mechanism of action of BCDF3, is unclear. It might induce growth of an 
sIgG  + subset of B  cells.  Alternatively, BCDF3"  might induce sIgG-  B  cells  to 
secrete IgG1. In the present studies, we have examined the effects of a BCDFT- 
containing T  cell SN on normal B cells in a limiting dilution culture system. Our 
results suggest that BCDF3,-containing SN induce IgG1 secretion in a subset of 
sIgG- B cells already committed to a  differentiation pathway leading to IgG1 
secretion. These cells do not arise from precursors of IgG3-secreting cells. 
Materials and Methods 
Animals.  We used female C57BL/6 × DBA/2  F~ (BDF1) mice (The Jackson Labora- 
tory, Bar Harbor, ME) 8-16 wk old. Lewis  rats (Harlan Sprague Dawley,  Inc., Indianapolis, 
IN), used at 3-6 wk, were a source of thymus cells. Rats were given tetracycline in their 
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drinking water (500  mg/pint)  for the  first  2  wk  after arrival  to prevent mycoplasma 
infections. 
Cell Preparation.  T  cell-depleted spleen cells (B cells) were prepared by treating cell 
suspensions with anti-Thy-1.2 monocionai antibody HO-13.4 and baby rabbit complement 
(Pel-Freez Biologicals, Rogers, AR). This treatment abolished the proliferative response 
to concanavalin A (Con A).  Rats were anesthetized with ether and exsanguinated from 
the axillary artery before removal of the thymus. Thymus cell suspensions were used as 
filler cells in the limiting dilution cultures. 
Specificity of the Anti-3" Antisera Used  for Fluorescence.  F(ab')2 fragments of rabbit anti- 
3' antibodies were prepared as described previously (26). Lymphoma cell lines were used 
for fluorescence analysis  of these anti-3" antibodies. An IgG2a-bearing subclone of A20 
(27) was  obtained from Dr.  Charlotte  Word,  UTHSC,  Dallas.  Two subclones,  BCL~a 
(sIgG1 +, sIgM  ÷) and BCL2b (sIgM+), derived from the in vitro BCL~ cell line (28), were 
provided by Dr. Yung-Wu Chen, UTHSC, Dallas (manuscript in preparation). An in vitro 
adapted clone of the AKR/J B iymphoma 225 was developed by Dr. K. Brooks, UTHSC, 
Dallas, from the in vivo lymphoma obtained from Dr. E. Ritchie, M. D. Anderson Hospital, 
Houston. This clone expresses sIgM and sIgD (K. Brooks, personal communication). 
Two control experiments were performed to establish the reactivity of the anti-3'  sera 
with  sIgG:  (a)  Two cell  lines  bearing sIgG  (A20  and  BCL~),  normal  splenic  B  cells 
stimulated with LPS for 5 d, and control slgG- cell lines (BCL2b and AKR/J-225) were 
stained with F(ab')~  rabbit anti-mouse 3' chain (RAM3')  and fluorescein isothiocyanate- 
goat anti-rabbit Ig (FITC-GARIg). Stained cells were analyzed on an Ortho 50H cyto- 
fluorograph (Ortho Diagnostic Systems, Inc., Westwood, MA). The slgG  ÷ cell lines were 
strongly positive, and the day-5 LPS blasts contained ~20% sIgG  ÷ cells. The intensity of 
staining of the LPS blasts was similar to that of the sIgG  ÷ cell lines, and <5% of the sIgG- 
cells  and cells  stained with  FITC-GARIg alone were positive. (b) 6-d  LPS blasts  were 
stained, sorted into sIgG  + and sIgG- populations, and analyzed for IgG3 plaque-forming 
cells (PFC). The staining had no effect on the total number of PFC obtained (25 PFC/10  ~ 
cells). The sorted sIgG  + cells gave a 5.5-fold higher PFC response than the sIgG- cells. 
Thus, staining with our antisera effectively identified and separated the sIgG  ÷ cells in the 
sorting procedure. 
Culture Conditions.  For limiting dilution cultures, varying numbers of splenic B cells 
were cultured with 3 ×  106 thymus cells/ml in RPMI  1640 medium with 20 mM Hepes, 
penicillin (50 u/ml), streptomycin (50 ug/ml), gentamycin (10 ug/ml), L-glutamine (2 raM) 
(Gibco Laboratories, Grand Island, NY),  50 #M 2-mercaptoethanol, and  10%  fetal calf 
serum (Hyclone; Sterile Systems, Inc. Logan, UT). 96-well, flat-bottomed microtiter plates 
(Costar, Cambridge, MA) were used. 48 wells, containing 0.2 ml cultures, were used for 
each concentration of B cells plated. A group containing no splenic B cells was included 
in each experiment to determine the background response from the thymus filler cells. 
This background was subtracted from the response of groups containing splenic B cells. 
Ig secretion was usually not observed. Cultures were incubated at 37°C in a humidified 
atmosphere of 83% N2, 7% O~, and  10% CO2 for 6 d. B cells were stimulated with 20 
•g/ml  LPS (Salmonella typhosa; Difco Laboratories Inc., Detroit, MI) with or without a 
source  of BCDF3'.  BCDF3"-containing SN  was  added  after  1  d  of culture.  In  some 
experiments, B cells were cultured at a concentration of 2.5 ×  I0  ~ cells/ml with 20 #g/ml 
LPS for 2-3  d.  This was  done in  75-cm  ~ tissue culture flasks  (Corning Glass  Works, 
Corning, NY) to generate blasts for cell sorting. 
T Cell SN.  Cells from the cloned alloreactive AKR anti-C57BL/6 T  cell line, PK 7.1, 
were maintained in culture as previously described (29). We induced lymphokine secretion 
by pulsing cells with  10 #g/ml Con A for 4 h, washing, and reculturing cells for 24 h in 
Con A-free medium. Such SN contain B cell growth factor (BCGF), B cell differentiation 
factor for IgM  (BCDFu) and  IgG (BCDF3"), colony-stimulating factors, and histamine- 
producing-cell-stimulating factor (HCSF or interleukin 3 [IL-3]), but not 3"-interferon, or 
conventional (30) T  cell-replacing factor (TRF) (16, 29, 31). 
PFC Assay.  We performed reverse PFC assays  in  96-well  microtiter plates (Linbro 
Chemical Co., Hamden, CT) by the method of Pike et al. (32). We prepared protein A- 1852  CLONAL ANALYSIS OF  IgG-SECRETING  CELLS 
coupled sheep erythrocytes by the method of Gronowicz et al. (33). Rabbit antisera specific 
for the heavy chains of mouse IgG1 and IgG3 were purchased from Litton Bionetics, Inc. 
(Kensington,  MD).  We  tested  the  specificity of these  reagents  by  showing  that  they 
developed reverse PFC only of the Ig class(es) shown to be present by radioimmunoassay 
(RIA) analysis (as described below). PFC assays of cells in limiting dilution cultures were 
performed after 6 d of culture. Wells with two or more PFC were scored as positive. We 
analyzed the data according to Poisson statistics as described by Lefkovits and Waidmann 
(34). 
RIAfor Secreted lg.  25-50 #1 of SN from 6-7 d limiting dilution cultures were assayed 
for secreted Ig by a  solid phase  RIA as previously described (35).  Briefly, plates were 
coated with affinity-purified rabbit anti-mouse Ig; secreted IgG in the SN was detected 
using  affinity-purified  ~25I-RAM3,1  or  ~5I-RAM~'3.  These  reagents  had  <1%  cross- 
reactivity with other heavy and  light  chains.  Purified  myeloma or hybridoma proteins 
were used as standards for quantitation.  In some experiments, limiting dilution cultures 
were assayed by the reverse PFC assay. We used an RIA for Ig secretion in the SN from 
the same cultures to determine the correlation of the two assays. Out of 150 wells assayed 
for IgG1, 91%  gave the  same results  in  both assays;  5%  were  PFC-positive, but  RIA 
negative, and 4% were negative for PFC, but positive in RIA. Out of 96 wells assayed for 
IgG3, 90% gave the same result in each assay; 6% were positive for PFC, but negative in 
RIA and 4% were RIA-positive, but PFC-negative. Correlation of the reverse PFC and 
RIA data showed that  1 PFC was equivalent to 0.2 ng of secreted IgG (1  ng/ml). Wells 
with ->2 PFC were scored as positive; ->2 ng/ml IgG was considered positive in the RIA. 
The number of cpm corresponding to 2 ng/ml was always greater than three standard 
deviations (SD) above the mean cpm obtained from thymus control groups. Since there 
was no more than a 2% difference between the number of positive wells using the reverse 
PFC assays and RIA, we used data from both assays to calculate the frequencies of IgG- 
secreting  B  cells.  Precursor  frequencies  were  calculated  by the  method  of maximum 
likelihood (36). 
The average clone size,  C,  of IgG-secreting B cells was calculated according to the 
following formula: C =  (~response)/(U x  Wr), where U is the number of precursors per 
well,  Wr is the total number of wells assayed and ~response is the total response (PFC or 
ng/ml IgG) from all wells assayed. 
Sorting of LPS-stimulated Cells.  B cells were cultured with LPS for 2-3 d, then washed, 
and the viable cells were separated on FicolI-Hypaque (density, 1.09 g/cc) (37). Cells were 
treated with F(ab')2 RAM~,  and FITC-GARIg (38).  Labeled cells were analyzed with a 
fluorescence-activated cell sorter (FACS) III (B-D FACS Systems, Becton, Dickinson and 
Co.,  Sunnyvale,  CA).  Large cells were sorted  directly into microtiter trays containing 
medium, thymus filler cells (3 x  106/ml), LPS (20 #g/ml), and/or PK 7.1 SN. For selection 
of slgG- cells, the 10-15% brightest (positive) cells were excluded. However, only 2-4% 
of cells  gave  staining  above  background  levels.  For  each  subset  of cells  sorted,  two 
different limiting concentrations of B cells were plated to determine precursor frequencies. 
We measured the response by RIA after 4 d of culture (a total of 6-7 d of culture), and 
the data were analyzed according to Poisson statistics (34). 
Replicate Cultures: Procedure and Data Analysis.  In some experiments, limiting dilution 
cultures were set up with 6 x  106 thymus cells/ml, 20 #g/ml LPS, and a concentration of 
splenic B cells that gave ~50% wells responding at the end of the culture. These cultures 
were divided in half after 3 d  of incubation and were restimulated with either LPS or 
LPS plus PK 7.1  SN. After a total of 7 d of incubation, the replicate cultures were assayed 
by RIA for secreted IgG3 or IgG1, respectively. The correlation of positive and negative 
wells  in replicates was determined. We used a two-tailed Fisher's exact test (39) to find 
the probability of obtaining each set of data, assuming independent  responses in  each 
replicate. This probability determines the significance of the correlation observed. The 
correlation coefficient (r,) was also calculated as described for dichotomous nominal scale 
data (40). rn is a measure of the degree of correlation and is independent of the level of 
significance of the data (P value). Therefore, it is necessary that the P value be significant; 
if it is, the rn value then indicates how strong the correlation is. In addition, two sets of LAYTON  ET  AL. 
TABLE  I 
Analysis  of Data 
Replicate 
1  2 
Percent of total wells 
tested 
Perfect positive correlation* 
a.  +  +  50 
b.  +  -  0 
c.  -  +  0 
d.  -  -  50 
Total:  n 
No correlation  * 
a.  +  +  25 
b.  +  -  25 
c.  -  +  25 
d.  -  -  25 
Total:  n 
* For these data, r, =  1.0, P < 0.001. 
* For these data, r, = 0, P > 0.9 (for 48 wells). 
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data can be compared by chi-square analysis of heterogeneity (41), which determines the 
probability that  the two sets of data are the same.  For two sets of replicate cultures  in 
which  50%  of the wells were positive in each  set,  the  two extremes  of possible results 
(perfect positive correlation vs. no correlation) are presented in Table I. There is also the 
possibility of negative correlation (r, -- -1.0), but none of the observed data fell into this 
category,  r,  is  calculated  as  follows:  r,  =  [(a  +  d) -  (b +  c)]/n,  where  a-d  represent 
respective rows of data in Table I. 
In conclusion, it should be stressed that the only valid comparison within an experiment 
is the comparison with the internal control. Comparisons between experiments  must be 
based  on  the  r.  values,  and  not  the  percentage  of positive  or  negative  wells  in  each 
experiment.  Furthermore,  the  r,  values  are  only valid  if the  P  values  are  significant 
(<0.01). 
Results 
Effect  of T  Cell-derived  BCDF'y-containing  SN on  the Precursor Frequency and 
Clone Size oflgG-secreting Cells.  Previous studies (16,  23) indicated  that in bulk 
cultures of LPS-stimulated splenic B cells IgG 1 secretion was increased ~ i 0-fold 
and  IgG3  secretion  was  decreased  3-fold  after  BCDF~,-containing  PK  7.1  SN 
was added.  A  change  in  the  precursor  frequency  and/or  size  of IgG-secreting 
clones might explain  these observations. 
To distinguish between these possibilities, we titrated B cells in limiting dilution 
cultures.  The  cells  were  stimulated  with  LPS  and,  after  1  d,  PK  7.1  SN  was 
added.  5  d  later,  IgG1  and  IgG3  secretion  were  determined  by  reverse  PFC 
assay or by RIA. Figs.  1 and  2  show the effects of PK 7.1  SN on the precursor 
frequencies  of IgG1- and  IgG3-secreting cells,  respectively.  As calculated  from 
the data  in these  figures,  PK 7.1  SN caused a  16-fold increase  in the precursor 
frequency  of IgGl-secreting  cells  and  a  6-fold  decrease  in  the  precursor  fre- 
quency of IgG3-secreting cells as compared  with cells cultured  with  LPS alone. 
PK 7.1  SN had no effect on the clone size of IgG3-secreting cells, but increased 1854  CLONAL  ANALYSIS  OF  IgG-SECRETING  CELLS 
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FIGURE  1.  BCDF~-containing PK  7.1  SN  induces an  increase m  precursor  frequency  of 
IgGl-secreting cells. Splenic B cells were cultured at limiting dilution in the presence of LPS 
(0) or LPS and PK 7.1  SN (O) for 6  d.  IgG1  secretion was determined by reverse PFC and 
RIA. Results from four experiments were pooled; each point represents 96-335 wells.  Error 
bars show the 95% confidence limits of each point. The following frequencies (I/n) (range) 
were obtained: for LPS, 272 (249-297); LPS +  PK 7.1 SN,  17.1  (15.1-19.4). 
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FIGURE  2.  BCDFT-containing PK 7.1 SN induces a decrease in precursor frequency of lgG3- 
secreting cells.  Limiting dilution cultures were set up as described in the legend of Fig.  1. 
lgG3  secretion was determined by reverse PFC  and RIA.  Results from three experiments 
were pooled; each point represents 60-156 wells.  Error bars show the 95% confidence limits 
of each  point.  Precursor  frequencies  (l/n)  (range)  of IgG3-secreting  B  cells were:  in  the 
presence of LPS (0) 27.5 (24.6-30.9) or of LPS and PK 7.1 SN (©) 161  (123-211). 
the clone size of IgGl-secreting cells 2.8-fold (Table  II).  Thus,  the increased 
levels of IgG 1 secretion induced by the addition of PK 7.1  SN to the limiting 
dilution cultures are due predominantly to an increase in the precursor frequency 
of IgGl-secreting cells. The suppression of IgG3 secretion, however, is caused 
solely by a decrease in precursor frequency of IgG3-secreting cells. 
BCDF~-containing  SN Induce  IgG1  Secretion of slgG- LPS Blasts.  Of impor- 
tance in understanding the mechanism of action of BCDF~,  is whether BCDF~ 
affects cells before or after expression of sIgG. Our previous investigations (16, 
25) indicate that BCDF'r does not bind to sIgG and does not act on cells that 
were sIgG  + before LPS activation. However, LPS activation induces expression 
of sIgG (18, 26, 42). Thus, we determined whether cells responding to BCDF~ LAYTON  ET  AL.  1855 
TABLE  II 
Effect of BCDFT-containing PK 7.1 SN on the Clone Size of lgG- 
secreting B Cells* 
Number of IgG-secreting  cells  per clone  Change  in clone 
lsotype secreted  in the presence of:*  size induced by 
LPS  LPS + PK 7.1 SN  PK 7.1 SN 
IgG3  17.3 -+ 3.1  19.7 +  2.1  None 
IgG1  18.9 "4- 1.6  52.3 -+ 6.0  2.8X 
* B cells were plated in limiting dilution cultures as described in Materials 
and Methods and Fig. 1. Secreted IgG was measured by RIA and the 
data were calculated from experiments shown in  Figs.  1 and 2.  The 
mean _+ SEM of three to six separate determinations from groups of 48 
wells is shown. 
* The clone size, C, was calculated according to the formula: C =  ~Re- 
sponse/U x  Wr, where Wr is the total number of wells assayed and U is 
the number of precursors per well. One PFC was shown to be equivalent 
to 1 ng/ml of secreted IgG (see Materials and Methods). 
TABLE  III 
Secretion of lgG1 by Total and slgG- B Cell Blasts Stimulated  With 
BCDFT-containing PK 7. I SN* 
Exp. 
Precursor frequency of lgG 1-secreting cells 
(1/n) 
Total blasts  slgG- blasts* 
1  143  92 
2  217  222 
3  130  101 
Mean _+ SEM  163 -+27  138 -+ 42 
* Splenic B cells were cultured with LPS (20 vg]ml) for 2 (Exp. 3) or 3 d 
(Exps.  1 and 2) and stained for slgG. Total blasts or sIgG- blasts were 
sorted on a FACS IIl into microtiter trays for limiting dilution analysis. 
After four more days of culture with PK 7.1 SN, secretion of IgG1 was 
determined by RIA and the precursor frequency determined by Poisson 
statistics. 
* Blasts had a mean forward light scatter on the FACS Ill of approximately 
twice that of the small cell population. 
were slgG  ÷ or slgG- after 3 d of LPS activation. We then compared the precursor 
frequency of IgGl-secreting  cells in sIgG- LPS blasts with the frequency in total 
LPS blasts when  both cell populations were cultured with PK  7.1  SN (it should 
be stressed that virtually all 3-d LPS blasts were sIgM  ÷, confirming earlier studies 
[26, 42]). Table III shows that the frequency with which clones of IgGl-secreting 
cells arose  was  similar in both  cell populations.  Thus,  most  cells which  secrete 
IgG1  after 7  d  of culture did not express sIgG after 3  d  of activation with LPS. 
Replicate  Culture  Experiments.  Although  the  experiments  described  in  the 
next two sections had different aims, the procedures  used were similar for both. 
Cultures of splenic B  cells were set up at limiting dilution, stimulated with LPS, 
then,  after  3  d  incubation,  divided  into  two  replicates.  The  replicates  were 
incubated  4  d  more,  then  assayed for  IgG secretion.  The  time  interval before 
the cultures were divided was sufficiently long to allow the responding clones to 1856  CLONAL  ANALYSIS  OF  IgG-SECRETING  CELLS 
have expanded to a point such that splitting resulted in a  measurable response 
in  both  halves.  We  had  to  divide  cultures early  enough,  however,  that  the 
addition of PK  7.1  SN would still  induce an easily measurable IgG1  response 
(delaying the addition of PK 7.1 SN reduces the magnitude of the IgG 1 response). 
Because the growth of responding clones is asynchronous, perfect correlation 
between the responses in the two replicate sets of cultures was not expected, and 
statistical methods were required to evaluate the data (see Materials and Meth- 
ods). 
Preliminary experiments established that day 3 was the earliest point cultures 
could be split and still give highly significant (P <  0.01) correlation of responses 
from identically treated replicates. When PK 7.1  SN was added on day 3,  the 
IgG1 precursor frequency was ~50% of that obtained when the SN was added 
on day 1. 
The number of splenic B cells per well was chosen so that ~50% of the wells 
were positive, i.e., there was an average of less than one precursor per well. It is 
easier to  show significant correlation with  even lower proportions  of positive 
wells,  but we were restricted in the number of cultures that could be set up by 
the availability of PK 7.1  SN, and lower proportions of positive wells would have 
required testing larger numbers of cultures. 
There was some variation in both the proportion of positive wells (apparently 
due to variation in the response of the cells from different groups of mice) and 
the degree of correlation obtained in individual experiments. Therefore, every 
experiment contained an internal control in which both replicates were stimu- 
lated with LPS and assayed for IgG3. Furthermore, it should be noted that even 
when  wells  scored  negative  for  IgG  secretion,  80-95%  of the  wells  in  all 
experiments were positive for IgM secretion, demonstrating that negative wells 
contained growing, IgM-secreting cells, rather than an absence of cells. 
Segregation of the Precursors of lgG1- and IgG3-secreting Cells.  The enhance- 
ment of IgG1  secretion and the suppression of IgG3 secretion induced by PK 
7.1  SN suggested that the SN was influencing cells to switch from IgG3 to IgG1. 
Alternatively, the SN could increase IgG1  and decrease IgG3 secretion of two 
different precursor populations. This might mean that the lymphokines causing 
these effects are different. 
Because PK 7.1 SN caused suppression of the IgG3 response (Fig. 2), we could 
not directly determine whether the same precursors gave rise to IgG1- and IgG3- 
secreting cells. Instead, replicate cultures were prepared as described, after 3 d 
stimulation with  LPS.  One set of cultures was  stimulated with  only LPS and 
assayed for IgG3 secretion, while the other replicate set was stimulated with LPS 
plus PK  7.1  SN and assayed for IgG1  secretion.  Wells giving IgG3  responses 
were correlated with  wells  giving IgG1  responses  (Table  IV,  protocol B).  In 
control cultures,  both  replicates were restimulated with  LPS  and assayed for 
IgG3 secretion (Table  IV,  protocol A).  The control cultures showed a  highly 
significant correlation of the IgG3  responses (P <  0.001),  and established the 
degree of correlation (rn =  0.672) that would be expected in Table IV B if IgG1- 
and IgG3-secreting cells were derived from the same precursors.  The data in 
Table IV B show that there was only a low degree of correlation (r, =  0.167) of 
IgG3 and IgG1  responses, indicating that most IgG3 and IgG1  precursors are LAYTON  ET  AL.  1857 
TABLE IV 
Segregation of Precursors of lgG1- and lgG3-secreting B Cells in Replicate Cultures* 
Cultures showing pat- 
Pattern of lgG secre-  tern of IgG secretion  Correlation 
Protocol  tion in replicate cul-  Significance 
tures  No. of  Percent of  (r,) 
wells  total 
A* 
B* 
LPS 
lgG3  IgG3 
+  +  101  53 
+  -  15  7.9 
-  +  16  8.5 
-  -  57  30 
LPS +  LPS  PK 7.1 
IgG1  lgG3 
+  +  55  29 
+  -  22  11 
-  +  58  30 
-  -  57  30 
P < 0.001  0.672 
P = 0.004  O. 167 
* Limiting dilution cultures were set up with 6 x  10  ~  thymus cells/ml, 20/~g/ml LPS, and 20 splenic 
B cells/well. After 3 d in culture, two replicate cultures were set up from each limiting dilution 
well. In protocol A (internal control), both replicate cultures were restimulated with LPS. After 4 
d, the SN were assayed for IgG3 by RIA and the correlation of positive and negative replicate 
cultures determined. In protocol B, one replicate culture was restimulated with LPS and the other 
replicate culture with LPS plus PK 7.1 SN. The SN from the replicate cultures restimulated with 
LPS were assayed for IgG3 and the SN from the replicate cultures stimulated with LPS plus PK 
7.1 SN were assayed for IgG1 by RIA. The correlation of the IgG1 with the lgG3 responses in the 
replicate cultures was determined and its significance calculated by Fisher's two-tailed exact test. 
* By chi-square analysis, the data from protocols A and B are significantly different (P < 0.001). 
independent of each other.  This low correlation was, however, significant (P = 
0.004). A  small proportion of clones probably give rise to both IgG1- and IgG3- 
secreting cells. 
Since the majority of IgGl-secreting clones do not arise from IgG3,secreting 
clones, it follows that  PK 7.1  SN does not induce a  switch from IgG3 t0  |gG1 
secretion.  Rather,  the suppression of IgG3 and enhancement of IgG1 secretion 
are separate effects, possibly caused by distinct components of PK 7.1  SN. IgG3 
secretion was also determined  in  the cultures  that had been  restimulated  with 
LPS and  PK  7.1  SN  (Table  V).  In six  separate  experiments,  two of which are 
shown in Table V, suppression of the IgG3 response, caused by the addition of 
PK 7.1  SN, varied from  12 to 38%  (data not shown).  Although this degree of 
suppression was substantially less than that seen when PK 7.1  SN was added on 
the first day of culture (Fig.  2),  we could not determine  whether it would bias 
the results.  Thus,  there  could be preferential  suppression  of IgG3 secretion in 
either the  IgGl-positive or IgGl-negative wells.  Such suppression would result 
in a  misleading correlation score.  However, the data in Table V  are similar  to 
the data obtained when the correlation was analyzed in replicate cultures (Table 
IV B).  The degree of correlation (rn)  of IgG1 and  IgG3 responses was slightly 1858  CLONAL  ANALYSIS  OF  IgG-SECRET1NG  CELLS 
TABLE  V 
Segregation of Precursors of lgG1- and lgG3-secreting B Cells in the Same Cultures* 
Pattern of lgG secre-  Cultures showing pat- 
tion in wells contain-  tern of IgG secretion  Correlation 
Significance 
Exp.  ing LPS +  PK 7.1  No. of  Percent of  (r.) 
SN  wells  total 
2 j 
IgG 1  IgG3 
+  +  55  29 
+  -  22  11  P <  0.001 
-  +  46  24 
-  -  69  36 
IgG1  IgG3 
+  +  63  33 
+  -  26  14  P <  0.001 
-  +  41  21 
-  -  62  32 
0.292 
0.302 
* See  footnotes to Tables  IV and VI  for experimental details.  IgG3  secretion was determined in 
cultures that had received LPS +  PK 7.1  SN after division of culture on day 3, rather than in the 
replicates that received only LPS; i.e., the same wells were analyzed for both IgG1 and IgG3. 
* Data  are  taken  from experiments in  Table  IV,  protocol  B.  The  precursor frequency of IgG3- 
secreting cells was  suppressed  21%  in  replicates  receiving  LPS  +  PK  7.1  SN,  compared  with 
replicates receiving LPS alone. 
0 Data from experiments in Table VI, protocol B. The precursor frequency of IgG3-secreting cells 
was  suppressed  32%  in  the  replicates  receiving  LPS  +  PK  7.1  SN,  compared  with  replicates 
receiving LPS alone. 
higher  in  Table V, as would be expected based on technical  considerations of 
analyzing the same wells for IgG1  and  IgG3,  rather  than  replicate wells (as in 
Table IV). In analyzing supernatants  from the same wells, the degree of corre- 
lation that would be expected if IgG1 and IgG3 precursors were the same is 1.0, 
rather than an experimentally determined control value, such as that shown in 
Table IV A. Thus, the conclusion reached from the data shown in Table IV B is 
further supported. The majority of IgG3- and IgGl-secreting clones arise from 
separate  precursors,  with a  small  proportion  of precursors  giving rise  to both 
IgG3- and IgGl-secreting progeny. 
LPS-stimulated B Cells Are Committed to lgG l Secretion Before Addition of  BCDF'y- 
containing SN.  As illustrated  in Table IV A,  when, after  3 d  in culture,  LPS- 
stimulated clones destined to secrete IgG3 were divided in half, a high proportion 
(86%) produced IgG3 in both halves after 7 d. This result implies that, after 3 d 
of stimulation, there were sufficient numbers of cells already committed to IgG3 
secretion such that each half would give an identical response 4 d later. A similar 
protocol was used to determine  whether clones destined to secrete IgG1  were 
already committed  to this  pathway before addition  of PK 7.1  SN,  or whether 
addition of PK 7.1  induced a commitment to IgG1 secretion. 
To address this issue, B cells were plated in  limiting dilution  cultures in the 
presence of LPS, and replicate cultures were prepared  3 d  later.  Cells in both 
replicas received PK 7.1  SN, and IgG 1 secretion was assayed 4 d  later.  Control LAYTON  ET  AL.  1859 
TABLE  VI 
Commitment of B Cells to IgG1 Secretion Before the Addition of BCDF'y-containing 
PK 7.1 SN* 
Protocol 
Cultures showing pat- 
Pattern of IgG secre-  tern of IgG secretion  Correlation 
tion in replicate cul-  Significance 
tures  No. of  Percent of  (r,) 
wells  total 
A* 
B* 
LPS 
IgG3  IgG3 
+  +  75  39 
+  -  21  11  P <  0.001 
-  +  19  10 
-  -  77  40 
LPS +  PK 7.1 
IgG 1  IgG 1 
+  +  70  37 
+  -  29  15  P <  0.001 
-  +  22  12 
-  -  70  37 
0.583 
0.466 
* Limiting dilution cultures were set up (as described in Table IV) in the presence of LPS and, after 
3 d  in culture, two replicate cultures were set up from each limiting dilution well. In protocol A 
(internal control), 20 splenic B cells were cultured per well. Replicate cultures were restimulated 
with LPS and assayed for  IgG3  secretion by  RIA after four additional days.  In protocol B,  30 
splenic B cells were cultured per well. Replicate cultures were restimulated with LPS plus PK 7.1 
SN and, after four more days, the culture SN were assayed for IgG1  by RIA. The correlation of 
positive and negative replicate cultures was determined. 
* By chi-square analysis, the data from protocols A and B are not significantly different (P =  0.24). 
cultures that were stimulated only with LPS and assayed for IgG3 were included 
in each experiment. 
We reasoned that if cultures were already committed to IgG1 secretion before 
the addition of PK 7.1, the correlation of IgG1 responses in the replicate cultures 
would be similar to that obtained with the IgG3 responses. On the other hand, 
if PK 7.1  SN induces a commitment to IgG1 secretion, then there should be no 
correlation of IgG 1 responses in the replicates, since commitment occurs after 
the cultures are split. The results presented in Table VI show that the correlation 
of both IgG3 (Table VI, protocol A) and IgG1 (Table VI, protocol B) responses 
was highly significant (P <  0.001) and that the degree of correlation of IgG1 
responses (rn =  0.466) was similar to that of IgG3 responses (rn =  0.583). Thus, 
clones stimulated by LPS are committed to IgG1  secretion before addition of 
PK  7.1  SN.  However,  PK  7.1  SN  is needed to  induce IgG1  secretion in  the 
committed B cells. 
Discussion 
Four major findings have emerged from these studies: (a) PK 7.1  SN induces 
a profound increase (16-fold) in the precursor frequency and a modest increase 
(2.8-fold) in the clone size of IgGl-secreting B cells; (b) cells responding to PK 1860  CLONAL  ANALYSIS  OF  IgG-SECRETING  CELLS 
7.1 SN lack sIgG 3 d after LPS activation; (c) the vast majority of IgGl-secreting 
cells are  derived  from  precursors  that  are  different  from  those giving rise  to 
IgG3-secreting cells; and (d) precursors of IgGl-secreting clones are committed 
to IgG 1 secretion before the addition of PK 7.1 SN. These committed cells lack 
sIgG and do not secrete IgG1  unless they are cultured with PK 7.1 SN. 
The  increase  in  precursor  frequency of IgGl-secreting cells induced  by PK 
7.1 SN suggests that this differentiation step is a directed process. Thus, BCDF7 
in  PK  7.1  SN  acts as a  differentiation  factor.  Since  PK  7.1  SN also contains 
growth  factors  (31),  the  modest increase  in  clone  size  of IgGl-secreting  cells 
might be caused by such factors. 
The finding that  PK 7.1  SN acts on sIgG- precursor cells extends the results 
of Isakson  et ai. (16), who reported that  the target  cell for BCDFT-containing 
SN does not bear sIgG before activation with LPS. It was possible, however, that 
PK 7.1 SN acts on cells that acquire sIgG as a result of LPS stimulation.  Indeed, 
Coutinho  et  al.  (18)  have  described  a  maturation  factor  that  induces  IgG1 
secretion  in  cells  already  expressing  sIgG1.  In  contrast,  in  our  experiments, 
removal of sIgG  + cells after LPS stimulation did not decrease the IgG1 response. 
Hence, PK 7.1 SN appears to differ from the lymphokines described by Coutinho 
et al. (18) since it acts on cells that are sIgG- after 3 d of LPS stimulation. 
The data in this report also demonstrate that the majority of IgGl-secreting 
cells do not arise from precursors of IgG3-secreting cells, but rather,  from an 
independent set of precursors. This suggests that most cells switch directly from 
IgM to IgG1, and few from IgM to IgG3 to IgG1. 
Finally, we have shown that cells are committed to IgG1  secretion before the 
addition of PK 7.1  SN. We envision two alternative pathways of differentiation 
during which commitment could occur (see Fig. 3). In the first pathway, receptors 
for BCDF7 appear before DNA rearrangement  and transcription  of C7~ genes; 
interaction of BCDF7 with its receptor induces rearrangement and transcription. 
In this pathway, commitment is manifested by the expression of BCDF7 recep- 
tors. In the second pathway, DNA rearrangements  occur before the appearance 
(i)  LPS  BCDFTR  BCDFy  ~i  ....  tmA  --  ylmm~  m~r~t~ 
J~"TIVATION  REARRANGEMENT  S 
W  W 
~'  I  BCDFy  S~3~ON  (2)  LPS  D~%  BCDFy  R  Yl mRNA 
~-TIVATION  RF_ARRANG~M~ 
FIGURE 3.  Diagrammatic representation of two alternative pathways for differentiation to 
IgG1  secretion. (V) The stage at which commitment to IgG1  secretion could occur. BCDF7 R 
is the receptor for BCDFT. LAYTON  ET  AL.  1861 
of BCDF'y receptors.  Rearrangements  would determine commitment if, subse- 
quently,  receptors  for  BCDFy  are  expressed,  and  binding  of BCDF3'  to  its 
receptor take place.  However, DNA rearrangements  might continue for heavy 
chain  constant  region  (C.)  genes  3'  to  C~'1, with  concomitant  expression  of 
receptors  for the  lymphokines  that  induce  secretion of other  isotypes.  In  this 
case, the initial rearrangement  for C~'1 expression would not necessarily consti- 
tute commitment  to IgG1  secretion.  To distinguish between these possibilities, 
it  would  be  helpful  to  raise  antibodies  to  the  BCDF3,  receptor,  so that  cells 
bearing the receptor can be purified and their  DNA analyzed for the relevant 
rearrangements. 
Summary 
To gain insight into how T  cell-derived lymphokines induce the secretion of 
IgG in activated B cells, we performed a limiting dilution analysis, using murine 
splenic B cells incubated with lipopolysaccharide (LPS) and a  T  cell-derived B 
cell differentiating  factor  for  IgG (BCDF~,)-containing  supernatant  (SN).  The 
results of this analysis indicate that such a SN induces a  marked increase in the 
precursor frequency of IgG 1-secreting cells and a modest increase in clone size. 
The  precursors  lack  surface  IgG  and  are  committed  to  the  differentiation 
pathway  for  IgG1  secretion  after  LPS  activation,  but  before the  addition  of 
BCDF3'-containing  SN.  The  majority of IgGl-secreting  clones arise independ- 
ently from precursors of cells that secrete IgG3. Taken  together,  these results 
indicate that BCDF3, directs differentiation of activated B cells to IgG 1 secretion. 
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